Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zoltán Urbányi"'
Autor:
Merle Nebel, Viktor Háda, Zoltán Urbányi, Tamás Schäfer, Róbert Kiss, Helga Hevér, Tanja Stadie, Piroska Kovács, Sonja Klingelhöfer
Publikováno v:
Biodrugs
Background In January 2017, the European Commission approved Terrosa® (company code RGB-10) as one of the first biosimilar medicinal products of teriparatide for the same indications as for the reference medicinal product Forsteo® (Lilly France S.A
Autor:
Zoltán Urbányi
Publikováno v:
Drug Discovery Today: Technologies. 40:1-2
Autor:
Zoltán Urbányi
Publikováno v:
Drug discovery today. Technologies. 38
The number of approved and marketed biosimilar monoclonal antibodies has been increasing steeply in recent years in regulated markets. In contrast to small molecular generic drugs, structure and variant profile of biosimilar mAbs are not identical wi
Publikováno v:
Journal of Chromatography B. 1032:224-229
Capillary electrophoresis techniques are widely used in the analytical biotechnology. Different electrophoretic techniques are very adequate tools to monitor size-and charge heterogenities of protein drugs. Method descriptions and development studies
Autor:
Gábor Szabó, Izabella Obál, Mária A. Deli, László Fábián, Szilvia Veszelka, Csongor S. Ábrahám, Zoltán Urbányi, Judit Laszy, Tamas Pazmany, Laszlo Nemeth
Publikováno v:
European Journal of Microbiology and Immunology. 3:281-289
Serum amyloid P component (SAP), a member of the innate immune system, does not penetrate the brain in physiological conditions; however, SAP is a stabilizing component of the amyloid plaques in neurodegenerative diseases. We investigated the cerebro
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 114
Capillary isoelectric focusing (cIEF) is a basic and highly accurate routine analytical tool to prove identity of protein drugs in quality control (QC) and release tests in biopharmaceutical industries. However there are some “ out-of-the-box ” a
Publikováno v:
Neurochemistry International. 46:471-477
Serum amyloid P component, a member of pentraxin serum protein family, has been suggested to contribute to the progression of neurodegeneration including Alzheimer's disease by binding to beta-amyloid fibrils leading to an increased stability of the
Autor:
Ngo Thi Khue Dung, Mária A. Deli, Zoltán Urbányi, Izabella Obál, Csongor S. Ábrahám, Szilvia Veszelka, Tamas Pazmany, Laszlo Nemeth, Gábor Szabó
Publikováno v:
Neuroscience Letters. 352:57-60
Endotoxin challenge leads to septic shock, multi-organ failure and death in mice. Permeability of the blood-brain barrier (BBB) is increased by endotoxemia. Serum amyloid P component (SAP) is a lipopolysaccharide (LPS)-binding protein that can modula
Autor:
Tamas Pazmany, Erzsébet Tóth, Éva Mekes, Zoltán Urbányi, Miklós Sass, Thomas B. Tomasi, Lajos László
Publikováno v:
Brain Research. 988:69-77
Previously we have reported serum amyloid P component (SAP) induced cell death in cerebro-cortical cultures of rat brain. In this paper we studied the types of target cells and the molecular mechanism of SAP-induced cell death. Immuno-electron and li
Autor:
Tibor Acs, Zoltán Urbányi, Judit Ovádi, Beáta G. Vértessy, János Kovács, Ferenc Orosz, Péter Löw, Tibor Keve
Publikováno v:
British Journal of Pharmacology. 121:947-954
1. KAR-2 (3"-(beta-chloroethyl)-2",4"-dioxo-3,5"-spiro-oxazolidino- 4-deacetoxy-vinblastine), is a bis-indol derivative; catharantine is coupled with the vindoline moiety which contains a substituted oxazolidino group. Our binding studies showed that